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Abstract
Background: Acute Otitis Media (AOM) is an important and common disease of childhood. Bacteria isolated from
cases of clinically problematic AOM in German children were identified and characterized.
Methods: In a prospective non-interventional study in German children between 3 months and less than 60
months of age with Ear, Nose and Throat Specialist –confirmed AOM, middle ear fluid was obtained by
tympanocentesis (when clinically indicated) or by careful sampling of otorrhea through/at an existing perforation.
Results: In 100 children with severe AOM, Haemophilus influenzae was identified in 21% (18/21, 85.7% were
non-typeable [NTHi]), Streptococcus pneumoniae in 10%, S. pyogenes in 13% and Moraxella catarrhalis in 1%. H.
influenzae was the most frequently identified pathogen in children from 12 months of age. H. influenzae and S.
pneumoniae were equally prevalent in children aged 3–11 months, but S. pyogenes was most frequently isolated in
this age group. NTHi AOM disease appeared prevalent in all ages.
Conclusions: NTHi, S. pneumoniae and S. pyogenes are implicated as important causes of complicated AOM in
children in Germany. NTHi disease appears prevalent in all ages. The impact of vaccination to prevent NTHi and S.
pneumoniae AOM may be substantial in this population and is worth investigating.
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Background
Acute Otitis Media (AOM) is one of the most fre-
quently reported childhood diseases and is the primary
reason for antibiotic use in children [1]. Globally, the
major bacterial pathogens responsible for AOM are
Streptococcus pneumoniae, Haemophilus influenzae and
to a lesser extent, Moraxella catarrhalis, S. pyogenes
and Staphylococcus aureus [2]. Little is known about
AOM microbial epidemiology in Germany. Perforation
of the tympanic membrane (TM) can occur as a conse-
quence of AOM. This has potentially important long
term clinical consequences [1].
Widespread vaccination with 7-valent pneumococcal
conjugate vaccine (PCV7) has reduced outpatient visits
due to AOM in children <2 years of age in the United
States, although the magnitude of the effect on AOM in-
cidence remains unclear [3]. PCV7 vaccination has also
been linked to an overall reduction in AOM cases due to
vaccine related S. pneumoniae, and a relative increase in
cases due to H. influenzae and non-vaccine S. pneumoniae
serotypes [4].
PCV7 was introduced to the German market in 2001
and became universally recommended for all infants in
2006. No available data from Germany has examined
pathogen distribution in AOM using direct Middle Ear
Fluid (MEF) sampling [5,6]. The aim of this prospective
non-interventional study was to assess the bacterial eti-
ology and antimicrobial susceptibility of bacteria causing
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AOM in 100 German children between 3 months and less
than 60 months of age. In Germany, tympanocentesis is
only indicated for treatment of complications of AOM,
treatment failure and in conditions of imminent TM per-
foration to avoid spontaneous perforation [7]. In our study,
MEF samples were collected from spontaneous TM rup-
tures by an Ear, Nose and Throat (ENT) specialist as part
of routine clinical ENT practice or when tympanocentesis
was clinically indicated.
The information from this study is important for
development and refinement of AOM treatment guide-
lines, and for assessing potential benefits of new PCVs.
Methods
The study (111640) was conducted in 11 centers in
Hamburg, Münster, Berlin, Dresden, München, and Bad
Segeberg in Germany. All children between 3 months and
less than 60 months of age with ENT specialist–confirmed
AOM were assessed for eligibility by the ENT specialist at
the study center. Written informed consent to analyze
MEF samples was obtained from the parents/guardians
of eligible children. The treatment of each child was left
to the discretion of the ENT specialist. The study proto-
col was approved by the local ethics committees: the
Ethik-Kommission bei der Ärztekammer Hamburg,
Ethik- Kommission der Medizinischen Fakultät der
Universität Münster, Ethik-Kommission der Sächsischen
Landesärztekammer, Ethik-Kommission der Bayerischen
Landesärztekammer, Ethik-Kommission der Ärztekammer
Schleswig-Holstein and the Ethik-Kommission der
Ärztekammer Berlin. MEF samples were collected by
the ENT specialist from spontaneous TM ruptures as part
of routine clinical ENT practice or when tympanocentesis
was clinically indicated.
Eligibility criteria
AOM diagnostic criteria were:1) acute onset of signs and
symptoms including fever, otalgia, irritability; 2) the
presence of MEF; and 3) recent onset (within 72 hours)
of signs and symptoms of middle-ear inflammation.
Children were eligible if they had a diagnosis of AOM;
and if a MEF sample had been obtained; and if they had
either not been previously treated with antibiotics, or if
they had treatment failure (no clinical improvement
within 48– to 72 hours of antibiotic treatment).
Children were not eligible if the following conditions
applied: if they been hospitalized for more than 48 hours
prior to the diagnosis of AOM perforation; if they had
otitis externa or non-acute otitis media with effusion; if
otorrhea was present for more than 48 hours prior to
sampling; if they had a trans-tympanic aerator in situ; if
they had received systemic antibiotic treatment for other
conditions 48 to 72 hours prior to study entry; or if they
had received prophylactic antibiotics for recurrent
AOM. Each child contributed one AOM episode to the
study.
Recurrent AOM was defined as the third or greater
new episode within the past 6 months, or the fourth or
greater new episode within the past year.
Study procedures
MEF was obtained by tympanocentesis or by careful
sampling of otorrhea through an existing perforation as a
routine procedure performed by the ENT specialist.
These procedures were performed under microscopic
visualization following removal of debris and cleaning of
the external auditory canal. Samples were inoculated onto
Amies transport medium (Copan Innovation transystem
Amies without carbon Reference 190C) and sent at
room temperature via courier to the National Reference
Laboratory (analysis managed by MvdL) within 16 hours
(maximum 72 hours). Initially transported samples were
partially frozen and the delivery services were subse-
quently changed. Samples were inoculated onto choc-
olate agar (otorrhea samples were inoculated onto
chocolate agar with bacitracin), blood (with gentamycin)
and MacConkey agar. Identification of S. pneumoniae,
H. influenzae, M. catarrhalis, and S. pyogenes was by
standard bacteriological procedures [8]. S. pneumoniae
serotypes were identified by Quellung reaction.
H. influenzae serotypes were identified using monovalent
anti-sera. Mean inhibitory concentrations (MIC) were
determined by microdilution tests interpreted according to
National Committee on Clinical Laboratory Standards
guidelines.
Results
Clinical and demographic characteristics of enrolled
subjects
One hundred and twelve children with AOM were
recruited between November 2008 and April 2010. Twelve
children did not meet the inclusion/criteria and were elimi-
nated from the According-to-protocol (ATP) cohort. Three
episodes were treatment failures (defined as no clinical
improvement within 48–72 hours of antibiotic treatment)
and the remaining 97 cases had not been previously treated
with antibiotics. The mean age of children was 35.2
months (range 3 to 59 months) and 44.0% were female.
Eight percent of the cases were in the age range 3 to 11
months, 15% were in the 12 to 23 month range, 26% were
in the 24 to 35 month range, 21% in the 36 to 47 month
range, and 30% in the 48 to 59 month age range.
The majority (74%) children had received at least one
PCV7 dose. Clinical symptoms such as fever >39.0°C,
ear discharge, lethargy, irritability and anorexia were
reported more frequently among children with cultures
positive for S. pneumoniae compared to children with
cultures positive for H. influenzae.
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There were 23 recurrent AOM cases (23% [95% confi-
dence interval CI: 15–32]). A total of 25% [95% CI: 3–65]
of cases were recurrent in 3–11 month olds, 27% [95% CI:
8–55] in 12–23 month olds, 31% [95% CI: 14–52] in 24–35
months, 19% [95% CI: 5–42] in 36–47 months and 17%
[95% CI: 6–35] in 48–59 month olds.
Microbiological results
One sample was collected from each child (otorrhea in
76 cases and MEF via tympanocentesis in 24 cases). In
each age group, the majority of samples were otorrhoea
(between 71% and 88% of all samples).
Of 100 samples, 44% (44/100) were culture positive for
one or more of the four bacteria under study: 21 (39.6%)
for H. influenzae, 10 (18.9%) for S. pneumoniae, 13
(24.5%) for S. pyogenes and 1 (2%) for M. catarrhalis.
Other bacteria including Pseudomonas aeruginosa and S.
aureus, were identified in 15 cases (Table 1). Both epi-
sodes positive for P. aeruginosa and all but one of 8 epi-
sodes positive for S. aureus were from otorrhoea
samples, possibly reflecting flora of the external auditory
canal.
Cultures were positive in 8/24 tympanocentesis samples
(33%) and 36/76 otorrhea samples (47%). H. influenzae was
identified in 18% of otorrhea samples and 29% of
tympanocentesis samples. S. pneumoniae and S. pyogenes
were isolated in 13% and 17% of otorrhea samples,
respectively. No tympanocentesis samples were positive
for S. pneumoniae or S. pyogenes.
H. influenzae was the most frequently identified patho-
gen in all age groups from 12 months of age (Figure 1):
18/21 (85.7%) H. influenzae isolates were non-typeable,
one was type b and one was type f. Of 10 S. pneumoniae
isolates, 6 were serotype 3, 3 were serotype 19A and 1
was serotype 1.
The distribution of pathogens was similar in PCV7-
vaccinated and unvaccinated subjects. For H, influenzae,
52% (11/21) of cases occurred in children who had
received 4 PCV7 doses.
Most (9/10, 90%) S. pneumoniae isolates were penicil-
lin sensitive and all were susceptible to other antibiotics,
including macrolides. Among Hi isolates, resistance to
trimethoprim/sulfamethoxazole was observed in 33%
(7/21), resistance to ampicillin in 19% (4/21) and resistance
to amoxicillin in 10% (2/21). None of the ampicillin resist-
ant strains were β-lactamase negative ampicillin resistant
strains.
Discussion
In this prospective study of AOM characteristics in
Germany, H. Influenzae was the most frequently identified
pathogen in children 12 months of age and older, and was
also frequently identified in 3–11 month olds, consistent
with a growing body of evidence implicating H. Influenzae
as a key pathogen in AOM [2,4], and of a possibly increas-
ing role due to PCV vaccination. S. pyogenes was the second
most frequently identified pathogen. These results are
consistent with preliminary results from another study
conducted in Germany [6], but contrast with other studies
suggesting a possibly diminishing role for S. pyogenes in
AOM etiology [2]. In a large evaluation of AOM etiology
conducted in Israel, S. pyogenes AOM was observed more
frequently in older children than in younger children, and
was often associated with acute TM perforation [9]. In our
study S. pyogenes was only isolated from otorrhea samples
(not from tympanocentesis samples), supporting the notion
that S. pyogenes infection rapidly leads to TM perforation
[9]. The high rate of S.pyogenes isolation in the present
study likely reflects the severity of disease in the enrolled
population (children with TM perforation or with clinically
Table 1 Bacterial etiology of episodes (ATP cohort)
Otorrhoea N = 76 Tympanocentesis N = 24 Total N = 100
Culture positive for n % n % n %
Any growth 43 57 10 42 53 53
Streptococcus pneumoniae 10 13 0 0 10 10
Haemophilus influenzae 14 18 7 29 21 21
Streptococcus pyogenes 13 17 0 0 13 13
Moraxella catarrhalis 0 0 1 4 1 1
Achromobacter spp. 1 8 0 0 1 7
Acinetobacter lwoffii 0 - 1 50 1 7
Coryneobacertium spp. 1 8 0 0 1 7
Escherichia coli 1 8 0 0 1 7
Pseudomonas aeruginosa 2 15 0 0 2 13
Staphylococcus aureus 8 62 1 50 9 60
N = number of episodes.
% = n/Number of episodes with available results x 100.
Note: More than one other bacteria was detected for some samples.
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indicated tympanocentesis according to German clinical
guidelines).
In the present cohort at least 74% of children had
received at least one PCV7 dose. Although the low
number of subjects precludes firm conclusions, the
results are generally consistent with larger observational
studies showing an increase in AOM due to non-PCV7
S. pneumoniae serotypes in countries where PCV7 uptake
is high [4]. New pneumococcal conjugate vaccines targeting
H. influenzae by use of Protein D as carrier protein
(PHiD-CV) [10], may provide additional benefits in
Germany.
In contrast with other countries in Europe, antibiotic
susceptibility rates were high in German children. This
may be due in part to reduced penicillin consumption in
Germany, which is lower than in many other countries
in Europe [11].
The potential limitations of the study include the low
number of culture-positive samples for which a cause
was not able to be identified, although the percentage of
positive cultures increased (from 43% to 61%) after
changes were made to ensure that sample delivery times
and temperature constraints were met. It is also possible
that the initial delay between sample collection and pro-
cessing might have introduced a bias toward a differen-
tial recovery of more resilient organisms. For example, S.
aureus and S. pyogenes are known to overgrow other
bacteria on swabs when processing delay increases, and
both S. pneumoniae and NTHi are fastidious organisms
more likely to perish after 6 hours and in conditions of
freezing.
Because tympanocentesis is not routinely performed
for AOM management in Germany, only children with
spontaneous perforations in which a specimen was
obtained using a procedure avoiding contamination or
those in whom tympanocentesis was clinically indicated
were eligible. Thus, our population had more severe
AOM and the results may not necessarily be able to be
extrapolated to all cases of AOM.
Conclusions
In the present study, NTHi, S. pneumoniae and S. pyogenes
were implicated as important causes of complicated AOM
in children in Germany. NTHi disease appeared prevalent
in all ages. The impact of vaccination to prevent both
S. pneumoniae and NTHi AOM may be substantial in this
population and is worth investigating.
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